Categories: News

SenseAnywhere Provides COVID-19 Vaccine Monitoring in Europe

PEPPERELL, Mass., Dec. 3, 2020 /PRNewswire-PRWeb/ — SenseAnywhere, a fully automated, wireless temperature monitoring system, will be used to monitor the temperature conditions of the COVID-19 vaccines in Europe in storage and transport. To monitor the conditions, SenseAnywhere will use its AiroSensors in combination with the PT100 smart probes ensuring safe distribution across Europe. Masy BioServices is proud to be the exclusive North American distributor of SenseAnywhere temperature monitoring system.

To learn more, visit our website http://www.masy.com/senseanywhere, call 978-433-6279, or email sales@masy.com to talk with a SenseAnywhere expert.

SenseAnywhere is the ideal monitoring system for all temperature conditions required for vaccine transport and storage. View your data through SenseAnywhere’s graphical interface from your computer or smart device 24-7, or use the API (Application Programming Interface) to integrate with your application. A ‘Plug and Play’ solution, SenseAnywhere’s calibrated loggers are simple to set up and offered at an affordable price point, while providing an impressive accuracy of +/- 0.1˚C.

About SenseAnywhere

SenseAnywhere manufactures very accurate, easy to use and long-lasting dataloggers, enabling fully automated temperature monitoring during storage or transport of temperature-sensitive products. The monitoring and mapping solutions are being used in all kinds of industries, among which are Food, Pharma and Logistics, all over the world.

About Masy BioServices

Masy BioServices has provided quality solutions to the life sciences community for over 35 years through an array of services, including calibration of primary standards and critical test equipment; validation and IQ/OQ/PQ of environmental chambers, autoclaves, and thermal warehouse mapping; and lab equipment rentals and sales. Masy has a premier cGMP biorepository, offering secure and tightly controlled temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds, and medical devices.

Follow us on LinkedIn – Masy BioServices

Press Contact:
Kristine LeBlanc
Senior Marketing Manager
Masy BioServices
Kristine.LeBlanc@masy.com
978-433-6279 x 1458

Media Contact

Kristine LeBlanc, Masy BioServices, +1 9784336279 Ext: 1458, kristine.leblanc@masy.com

Twitter, Facebook

 

SOURCE Masy BioServices

Staff

Recent Posts

The Power of Tracking: New Preliminary Data Underscores How MyFitnessPal Supports Weight Management Goals

Research highlights how nutrition tracking drives success for weight loss and health goals NEW YORK,…

7 minutes ago

Vivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide

Richland, WA, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to…

3 hours ago

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing…

3 hours ago

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company…

3 hours ago